These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 31105666)

  • 21. High-level telithromycin resistance in laboratory-generated mutants of Streptococcus pneumoniae.
    Walsh F; Willcock J; Amyes S
    J Antimicrob Chemother; 2003 Sep; 52(3):345-53. PubMed ID: 12917252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lack of correlation between reduced outpatient consumption of macrolides and macrolide resistance of invasive Streptococcus pneumoniae isolates in Slovenia during 1997-2017.
    Kastrin T; Paragi M; Erčulj V; Žohar Čretnik T; ; Bajec T; Čižman M
    J Glob Antimicrob Resist; 2019 Mar; 16():242-248. PubMed ID: 30391398
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phenotypes and genotypes of macrolide-resistant streptococcus pneumoniae.
    Sirekbasan L; Gönüllü N; Sirekbasan S; Kuşkucu M; Midilli K
    Balkan Med J; 2015 Jan; 32(1):84-8. PubMed ID: 25759777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genotyping and serotyping of macrolide and multidrug resistant Streptococcus pneumoniae isolated from carrier children.
    Swedan SF; Hayajneh WA; Bshara GN
    Indian J Med Microbiol; 2016; 34(2):159-65. PubMed ID: 27080766
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Erythromycin resistance and genetic elements carrying macrolide efflux genes in Streptococcus agalactiae.
    Marimón JM; Valiente A; Ercibengoa M; García-Arenzana JM; Pérez-Trallero E
    Antimicrob Agents Chemother; 2005 Dec; 49(12):5069-74. PubMed ID: 16304174
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trends in antibacterial resistance among Streptococcus pneumoniae isolated in the USA: update from PROTEKT US Years 1-4.
    Jenkins SG; Brown SD; Farrell DJ
    Ann Clin Microbiol Antimicrob; 2008 Jan; 7():1. PubMed ID: 18190701
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Resistance Genes and Genetic Elements Associated with Antibiotic Resistance in Clinical and Commensal Isolates of Streptococcus salivarius.
    Chaffanel F; Charron-Bourgoin F; Libante V; Leblond-Bourget N; Payot S
    Appl Environ Microbiol; 2015 Jun; 81(12):4155-63. PubMed ID: 25862227
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation between usage of macrolide antibiotic and resistance of Streptococcus pneumoniae clinic isolates from Chongqing children's hospital.
    Chen J; Liu L; Wang G; Chen Y; Luo Z; Huang Y; Fu Z; Yang Y; Liu E
    Pediatr Pulmonol; 2009 Sep; 44(9):917-21. PubMed ID: 19670405
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distribution of capsular serotypes and macrolide resistance mechanisms among macrolide-resistant Streptococcus pneumoniae isolates in Korea.
    Bae S; Lee K
    Diagn Microbiol Infect Dis; 2009 Feb; 63(2):213-6. PubMed ID: 19097840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. mef(A) is the predominant macrolide resistance determinant in Streptococcus pneumoniae and Streptococcus pyogenes in Germany.
    Bley C; van der Linden M; Reinert RR
    Int J Antimicrob Agents; 2011 May; 37(5):425-31. PubMed ID: 21419605
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative activity of telithromycin against macrolide-resistant isolates of Streptococcus pneumoniae: results of two years of the PROTEKT surveillance study.
    Schito GC; Marchese A; Elkharrat D; Farrell DJ;
    J Chemother; 2004 Feb; 16(1):13-22. PubMed ID: 15077994
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evolution of macrolide resistance in Streptococcus pneumoniae clinical isolates in the prevaccine era.
    Daikos GL; Koutsolioutsou A; Tsiodras S; Theodoridou M; Koutouzis EI; Charissiadou A; Pangalis A; Michos AG; Chaidopoulou F; Braoudaki M; Syriopoulou VP
    Diagn Microbiol Infect Dis; 2008 Apr; 60(4):393-8. PubMed ID: 18077121
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of macrolide resistance and in vitro activities of six antimicrobial agents against clinical isolates of Streptococcus pneumoniae from a multi-center surveillance in Malaysia.
    J J; M T N; M D MN; M SN; M Y R; J F; S R S; K A
    Med J Malaysia; 2013 Apr; 68(2):119-24. PubMed ID: 23629556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serogroup 19 pneumococci containing both mef and erm macrolide resistance determinants in an American city.
    Toltzis P; Dul M; O'Riordan MA; Jacobs MR; Blumer J
    Pediatr Infect Dis J; 2006 Jan; 25(1):19-24. PubMed ID: 16395097
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Mobile genetic elements associated with erythromycin-resistant isolates of Streptococcus pneumoniae in Colombia].
    Ramos V; Duarte C; Díaz A; Moreno J
    Biomedica; 2014 Apr; 34 Suppl 1():209-16. PubMed ID: 24968052
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacodynamic activity of azithromycin against macrolide-susceptible and -resistant Streptococcus pneumoniae simulating clinically achievable free serum, epithelial lining fluid and middle ear fluid concentrations.
    Zhanel GG; DeCorby M; Noreddin A; Mendoza C; Cumming A; Nichol K; Wierzbowski A; Hoban DJ
    J Antimicrob Chemother; 2003 Jul; 52(1):83-8. PubMed ID: 12775677
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence of antimicrobial resistance-conferring genetic elements among pneumococci isolated prior to 1974.
    Wyres KL; van Tonder A; Lambertsen LM; Hakenbeck R; Parkhill J; Bentley SD; Brueggemann AB
    BMC Genomics; 2013 Jul; 14():500. PubMed ID: 23879707
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular epidemiology and prevalence of macrolide efflux genes mef(A) and mef(E) in Streptococcus pneumoniae obtained in Canada from 1997 to 2002.
    Wierzbowski AK; Swedlo D; Boyd D; Mulvey M; Nichol KA; Hoban DJ; Zhanel GG
    Antimicrob Agents Chemother; 2005 Mar; 49(3):1257-61. PubMed ID: 15728944
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of erythromycin-resistant Streptococcus pneumoniae in Korea, and In Vitro activity of telithromycin against erythromycin-resistant Streptococcus pneumoniae.
    Kim NJ; Park SJ; Choi SH; Lee MS; Choo EJ; Kwak YG; Woo JH; Ryu J; Jeong JY; Kim YS
    Microb Drug Resist; 2005; 11(3):260-5. PubMed ID: 16201929
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genotypes of macrolide-resistant pneumococci from children in southwestern Japan: raised incidence of strains that have both erm(B) and mef(A) with serotype 6B clones.
    Ikenaga M; Kosowska-Shick K; Gotoh K; Hidaka H; Koga H; Masunaga K; Nagai K; Tsumura N; Appelbaum PC; Matsuishi T
    Diagn Microbiol Infect Dis; 2008 Sep; 62(1):16-22. PubMed ID: 18068325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.